Tert-butyl (3S,4S)-3-[benzyl-[(1R)-1-phenylethyl]amino]-4-(dibenzylamino)-6-methylheptanoate
C41H52N2O2 — CID 139038052
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl (3S,4S)-3-[benzyl-[(1R)-1-phenylethyl]amino]-4-(dibenzylamino)-6-methylheptanoate
Tert-butyl (3S,4S)-3-[benzyl-[(1R)-1-phenylethyl]amino]-4-(dibenzylamino)-6-methylheptanoate (PubChem CID 139038052) has the molecular formula C41H52N2O2 and a molecular weight of 604.88 g/mol. Its IUPAC name is tert-butyl (3S,4S)-3-[benzyl-[(1R)-1-phenylethyl]amino]-4-(dibenzylamino)-6-methylheptanoate.
Molecular Properties
| Compound Name | Tert-butyl (3S,4S)-3-[benzyl-[(1R)-1-phenylethyl]amino]-4-(dibenzylamino)-6-methylheptanoate |
|---|---|
| PubChem CID | 139038052 |
| Molecular Formula | C41H52N2O2 |
| Molecular Weight | 604.88 g/mol |
| Exact Mass | 604.40 |
| IUPAC Name | tert-butyl (3S,4S)-3-[benzyl-[(1R)-1-phenylethyl]amino]-4-(dibenzylamino)-6-methylheptanoate |
| SMILES | CC(C)C[C@@H]([C@H](CC(=O)OC(C)(C)C)N(Cc1ccccc1)[C@H](C)c1ccccc1)N(Cc1ccccc1)Cc1ccccc1 |
| InChI | InChI=1S/C41H52N2O2/c1-32(2)27-38(42(29-34-19-11-7-12-20-34)30-35-21-13-8-14-22-35)39(28-40(44)45-41(4,5)6)43(31-36-23-15-9-16-24-36)33(3)37-25-17-10-18-26-37/h7-26,32-33,38-39H,27-31H2,1-6H3/t33-,38+,39+/m1/s1 |
| InChIKey | KMXHOJUSICZIJE-IUNOAQLMSA-N |
| XLogP | 9.47 |
| TPSA | 32.78 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 604.88 |
| LogP ≤ 5 | 9.47 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139038052 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.